NeuroOne Medical Technologies Corporation
NMTC
$0.823
$0.0658.58%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.76M | 5.75M | 3.45M | 3.92M | 3.73M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.76M | 5.75M | 3.45M | 3.92M | 3.73M |
| Cost of Revenue | 6.17M | 6.57M | 6.24M | 7.32M | 7.86M |
| Gross Profit | -414.20K | -816.60K | -2.79M | -3.40M | -4.14M |
| SG&A Expenses | 7.71M | 7.77M | 7.90M | 7.64M | 7.62M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -3.00M | -3.00M | -- | -- | -- |
| Total Operating Expenses | 12.34M | 12.54M | 15.34M | 16.16M | 16.68M |
| Operating Income | -6.58M | -6.79M | -11.89M | -12.24M | -12.95M |
| Income Before Tax | -6.60M | -7.19M | -12.32M | -12.10M | -12.80M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.60 | -7.19 | -12.32 | -12.10 | -12.80 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.60M | -7.19M | -12.32M | -12.10M | -12.80M |
| EBIT | -6.58M | -6.79M | -11.89M | -12.24M | -12.95M |
| EBITDA | -6.32M | -6.53M | -11.64M | -11.99M | -12.71M |
| EPS Basic | -0.23 | -0.27 | -0.46 | -0.49 | -0.59 |
| Normalized Basic EPS | -0.15 | -0.17 | -0.29 | -0.31 | -0.37 |
| EPS Diluted | -0.23 | -0.27 | -0.46 | -0.49 | -0.59 |
| Normalized Diluted EPS | -0.15 | -0.17 | -0.29 | -0.31 | -0.37 |
| Average Basic Shares Outstanding | 119.11M | 113.91M | 107.07M | 99.52M | 89.75M |
| Average Diluted Shares Outstanding | 119.16M | 113.95M | 107.07M | 99.52M | 89.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |